Document is current

Any future updates will be listed below

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

Crossref DOI link: https://doi.org/10.1007/s00277-015-2580-z

Published Online: 2015-12-22

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark